Summary of Purpose
The purpose of the study is to use data from a health care information database to assess the risk of venous thromboembolism (blood clots), myocardial infarction (heart attacks), and stroke among women using a transdermal contraceptive system (ORTHO EVRA) for birth control compared with women using norgestimate-containing oral contraceptives with 35 mcg ethinyl estradiol.Read More →
The following dates are available for this trial. Trial information last updated on 15 July 2016.
|1 Apr 2002||15 Sep 2006||1 Oct 2008||1 Oct 2008||1 Jul 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Case Control
- Perspective: Retrospective
- Sampling: Non-Probability Sample